Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 19, 2026.
A leading biomedical and genomic research institution associated with MIT and Harvard, dedicated to understanding and treating human disease by advancing genomics and related biomedical sciences. Its initiatives include the Single Cell Portal, which serves as an open-access platform to accelerate single-cell research by hosting and enabling exploration of a vast number of studies and associated data.
The public category test is directional and too small to support a high-confidence rating.
Optimly has not yet published a supported competitor set for Broad-institute-of-mit-and-harvard.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Official website: https://singlecell.broadinstitute.org/
Last analyzed: August 19, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile